Analyst price target range
Sutro Biopharma Price Target: $47.23 Average
STRO target range is $10.00 to $61.00. As of 2026-08-19.
Direct answer
Sutro Biopharma's average price target is $47.23.
The verified analyst range runs from $10.00 to $61.00.
The low target implies -54.6%, the high target implies +176.8%, and the range spans 231.4% of the current price.
Forecast evidence checked August 19, 2026.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $22.04
- Average price target
- $47.23
- High price target
- $61.00
- Low price target
- $10.00
- Low target gap
- -54.6%
- Target upside
- +114.3%
- High target gap
- +176.8%
- Target range width
- 231.4%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is Sutro Biopharma's average price target?
Sutro Biopharma's verified average price target is $47.23. The target range is $10.00 to $61.00.
How far are Sutro Biopharma's low and high targets from the recorded price?
The low target implies -54.6%, while the high target implies +176.8%.
How many analysts are included in Sutro Biopharma's consensus?
The verified consensus includes 13 analysts.
How is Sutro Biopharma's target upside or downside calculated?
The average target of $47.23 is divided by the recorded price of $22.04, then one is subtracted to produce +114.3%. This does not guarantee a future return.
When was Sutro Biopharma's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.